Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

Supplementary Figures S1-S4 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial

<p>Supplementary Figure 1: Study flow-chart. Supplementary Figure 2: Kaplan-Meier curves of event-free survival according to tertile-split tumor mutational burden. Supplementary Figure 3. Kaplan-Meier curves of recurrence-free survival according to the molecular subtype. Supplementary Figure 4...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: Giuseppe Basile (15051269) (author)
Outros autores: Marco Bandini (15051272) (author), Ewan A. Gibb (15051275) (author), Jeffrey S. Ross (15030824) (author), Daniele Raggi (15051278) (author), Laura Marandino (15051281) (author), Tiago Costa de Padua (15051284) (author), Emanuele Crupi (15051287) (author), Renzo Colombo (15051290) (author), Maurizio Colecchia (15051293) (author), Roberta Lucianò (15051296) (author), Luigi Nocera (15051299) (author), Marco Moschini (15051302) (author), Alberto Briganti (15051305) (author), Francesco Montorsi (15051308) (author), Andrea Necchi (15044772) (author)
Publicado: 2025
Subjects:
Cancer
Immuno-oncology
Clinical Research and Trials
Clinical Trial Results
Phase II clinical trials
Genitourinary Cancers
Bladder cancer
Immunotherapy
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
Sexa o primeiro en deixar un comentario!
You must be logged in first

Títulos similares